Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Sunesis Pharmaceutic (SNSS)

Sunesis Pharmaceutic (SNSS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sunesis Pharmaceutic 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 USA

P: 650-266-3500 F: 650-266-3501

Description:

Sunesis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. It has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. It is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies.

Key Statistics

Overview:

Market Capitalization, $K 57,877
Shares Outstanding, K 72,528
Annual Sales, $ 240 K
Annual Net Income, $ -26,620 K
60-Month Beta 2.75
% of Insider Shareholders 4.22%
% of Institutional Shareholders 43.10%
Float, K 69,467
% Float 95.78%

Growth:

1-Year Return -66.89%
3-Year Return -73.40%
5-Year Return -98.01%
5-Year Revenue Growth -96.98%
5-Year Earnings Growth 81.06%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/06/19
Earnings Per Share ttm -0.44
EPS Growth vs. Prev Qtr 37.50%
EPS Growth vs. Prev Year 52.38%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-6 on 09/08/16

SNSS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -2.32
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) 0.00
Return-on-Assets (Before Tax) -116.30
Profit Margin % -11,091.67
Net Margin % N/A
Debt/Equity N/A
Price/Sales 278.24
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.12
Interest Coverage -22.15
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar